Back

Implantable cardioverter defibrillators in type 1 diabetes regarding indications, complications and prognosis

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Cardiac implantable electronic devices therapy: from implant strategy to long-term management Implantable Cardioverter-Defibrillator (ICD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tigist Wodaje

Karolinska University Hospital, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Ultrasound-guided combined PECS II and parasternal intercostal nerve block versus conventional local anesthesia for cardiac implantable electronic cevice emplantation: a prospective controlled Study
Doctor C. Korucu (Sanliurfa, TR)
Presentation thumbnail
Implantable devices in chronic Chagas cardiomyopathy: outcomes and a delayed response to CRT in a real-world cohort
Mr C. Calderon Franco (Bogota, CO)
Abstract Slides
Presentation thumbnail
Age and triggers of inappropriate implantable cardioverter-defibrillator therapy in primary prevention patients
Associate Professor A. Barsheshet (Petah Tikva, IL)
Abstract Slides
Presentation thumbnail
Early real-world outcomes of the 2023 refined dutch guidelines for non-ischemic cardiomyopathy mandating CRT-P treatment
Ms L. Broers (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Impaired sinus response during ventricular arrhythmia predicts adverse outcomes in implantable cardioverter-defibrillator recipients
Doctor M. Blondeel (Leuven, BE)
Abstract Slides

Access the full session

Session thumbnail
Cardiac implantable electronic devices therapy: from implant strategy to long-term management

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Insulin treatment is associated with increased risk of device-treated ventricular tachyarrhythmia in patients with diabetes and heart failure
2 September 2019
thumbnail
Congress Presentation
A 25-year single-center experience with transvenous and subcutaneous ICD patients under thirty years of age.
17 April 2023
thumbnail
Congress Presentation
Is ECG alone enough? In type 1 diabetes patients, an ECG stress test is mandatory before engaging in high-intensity sports
4 April 2025
thumbnail
Congress Presentation
Indications, prognosis, and complications of de novo implantable cardioverter defibrillators in patients with type 2 diabetes and without diabetes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources